UCL has made dementia a priority
Dementia is the greatest scientific, medical and socio-economic challenge of our times and affects more than 46 million people worldwide. As populations age, dementia is inevitably going to become more common with devastating personal, social and economic implications.
UCL can lay claim to world-leading expertise across the spectrum of research, from genetics to evidence based treatments and support for patients and carers. We have both the ambition and ability to make a difference and meet the challenge of this most pressing of global public health problems.
The UK Dementia Research Institute is a joint investment into dementia research led by the Medical Research Council alongside founding charity partners Alzheimer’s Society and Alzheimer’s Research UK. The Institute will be catalytic in the UK’s research efforts to diagnose, treat, care for and prevent dementias, a group of neurodegenerative disorders which include Alzheimer’s, Parkinson’s, Huntington’s disease and vascular dementia. The hub of the institute activity and operational headquarters is based at UCL.
UCL researchers have developed a quick and simple test to predict which people with early-stage Parkinson’s disease are likely to develop dementia.
Published: Oct 16, 2017 2:49:03 PM
Professor Bart de Strooper, who has won the 2017 European Grand Prize for
Research from the Alzheimer Research Foundation.
Professor de Strooper is
the Director of the UK Dementia Research Institute (UK DRI) and Head of
Department of the UK DRI at UCL. He was recognised for the Foundation for his
major contributions to the field of Alzheimer’s disease.
Published: Oct 4, 2017 1:02:07 PM